Together, these interventions provide comprehensive renoprotection by lowering apoptosis (reduced BAX and increased BCL-2) and suppressing TGF-β-driven fibrosis, thereby preserving renal integrity and preventing long-term damage in DN. This evidence concerns the gene BCL2 and liver dysplastic nodule.